Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Emre Kara, Kamer Tecen Yucel, Aygin Bayraktar-Ekincioglu, Kutay Demirkan, Lale Tokgozoglu & Serhat Unal. (2020) Evaluation of internal medicine physicians’ attitudes toward the treatment of dyslipidemia. Postgraduate Medicine 132:6, pages 538-543.
Read now
Read now
Peter Lansberg, Andre Lee, Zhen-Vin Lee, Kannan Subramaniam & Sajita Setia. (2018) Nonadherence to statins: individualized intervention strategies outside the pill box. Vascular Health and Risk Management 14, pages 91-102.
Read now
Read now
Sajita Setia, Nicola J Ryan, Prasad S Nair, Elma Ching & Kannan Subramaniam. (2018) Evolving role of pharmaceutical physicians in medical evidence and education. Advances in Medical Education and Practice 9, pages 777-790.
Read now
Read now
Articles from other publishers (18)
Fahmi Y. Al-Ashwal, Syed Azhar Syed Sulaiman, Siti Maisharah Sheikh Ghadzi, Mohammed Abdullah Kubas & Abdulsalam Halboup. (2023) Physicians and pharmacists’ clinical knowledge of statin therapy and monitoring parameters, and the barriers to guideline implementation in clinical practice. PLOS ONE 18:1, pages e0280432.
Crossref
Crossref
Fatemeh Koohi, Karim Kohansal, Marzieh Saei Ghare Naz, Somayeh Derakhshan, Fereidoun Azizi & Davood Khalili. (2022) The trend of 10-year cardiovascular risk among diabetic and non-diabetic participants in Tehran Lipid and glucose study: 1999–2018. BMC Public Health 22:1.
Crossref
Crossref
Fahmi Y. Al-Ashwal, Syed Azhar Syed Sulaiman, Siti Maisharah Sheikh Ghadzi, Mohammed Abdullah Kubas & Abdulsalam Halboup. (2022) Risk assessment of atherosclerotic cardiovascular diseases before statin therapy initiation: Knowledge, attitude, and practice of physicians in Yemen. PLOS ONE 17:5, pages e0269002.
Crossref
Crossref
Ravi Jandhyala. (2022) Development and Validation of the Medical Affairs Pharmaceutical Physician Value (MAPPval) Instrument. Pharmaceutical Medicine 36:1, pages 47-57.
Crossref
Crossref
Ravi Jandhyala. (2022) Professional qualifications of medical affairs pharmaceutical physicians and other internal stakeholders in the pharmaceutical industry. F1000Research 11, pages 813.
Crossref
Crossref
Ravi Jandhyala. (2022) Professional qualifications of medical affairs pharmaceutical physicians and other internal stakeholders in the pharmaceutical industry. F1000Research 11, pages 813.
Crossref
Crossref
Hae-Young Lee & Jeong Bae Park. 2022. Textbook of Arterial Stiffness and Pulsatile Hemodynamics in Health and Disease. Textbook of Arterial Stiffness and Pulsatile Hemodynamics in Health and Disease
491
501
.
Hae-Young Lee, Ki-Hoon Han, Woo-Baek Chung, Sung-Ho Her, Tae-Ho Park, Seung-Woon Rha, So-Yeon Choi, Kyung-Tae Jung, Jong-Seon Park, Pum-Joon Kim, Jong-Min Lee, Myung-Ho Jeong, Eun-Seok Shin, Hyeon-Cheol Gwon, Kyoo-Rok Han, Jei-Keon Chae, Woo-Shik Kim, Dong-Ju Choi, Bum-Kee Hong, Si-Wan Choi & Namsik Chung. (2020) Safety and Efficacy of Pitavastatin in Patients With Impaired Fasting Glucose and Hyperlipidemia: A Randomized, Open-labeled, Multicentered, Phase IV Study. Clinical Therapeutics 42:10, pages 2036-2048.
Crossref
Crossref
Perrine Courlet, Françoise Livio, Susana Alves Saldanha, Alexandra Scherrer, Manuel Battegay, Matthias Cavassini, Marcel Stoeckle, Laurent Arthur Decosterd, Catia Marzolini, K Aebi-Popp, A Anagnostopoulos, M Battegay, E Bernasconi, J Böni, D L Braun, H C Bucher, A Calmy, M Cavassini, A Ciuffi, G Dollenmaier, M Egger, L Elzi, J Fehr, J Fellay, H Furrer, C A Fux, H F Günthard, D Haerry, B Hasse, H H Hirsch, M Hoffmann, I Hösli, M Huber, C R Kahlert, L Kaiser, O Keiser, T Klimkait, R D Kouyos, H Kovari, B Ledergerber, G Martinetti, B Martinez de Tejada, C Marzolini, K J Metzner, N Müller, D Nicca, P Paioni, G Pantaleo, M Perreau, A Rauch, C Rudin, A U Scherrer, P Schmid, R Speck, M Stöckle, P Tarr, A Trkola, P Vernazza, G Wandeler, R Weber & S Yerly. (2020) Real-life management of drug–drug interactions between antiretrovirals and statins. Journal of Antimicrobial Chemotherapy 75:7, pages 1972-1980.
Crossref
Crossref
Shuju Dong, Jian Guo, Jinghuan Fang, Ye Hong, Shuhui Cui & Li He. (2019) Low-dose statin pretreatment reduces stroke severity and improves functional outcomes. Journal of Neurology 266:12, pages 2970-2978.
Crossref
Crossref
Yun Wang, Bryan P Yan, Brian Tomlinson & Vivian WY Lee. (2019) Is lipid goal one-size-fits-all: A review of evidence for recommended low-density lipoprotein treatment targets in Asian patients. European Journal of Preventive Cardiology 26:14, pages 1496-1506.
Crossref
Crossref
KK Poh, CT Chin, KL Tong, JKB Tan, JS Lim, W Yu, M Horack, A Vyas, D Lautsch, B Ambegaonkar, P Brudi & AK Gitt. (2019) Cholesterol goal achievement and lipid-lowering therapy in patients with stable or acute coronary heart disease in Singapore: results from the Dyslipidemia International Study II. Singapore Medical Journal 60:9, pages 454-462.
Crossref
Crossref
Isao TaguchiSatoshi IimuroHiroshi IwataHiroaki TakashimaMitsuru AbeEisuke AmiyaTakanori OgawaYukio OzakiIchiro SakumaYoshihisa NakagawaKiyoshi HibiTakafumi HiroYoshihiro FukumotoSeiji HokimotoKatsumi MiyauchiTsutomu YamazakiHiroshi ItoYutaka OtsujiKazuo KimuraJun TakahashiAtsushi HirayamaHiroyoshi YokoiKazuo KitagawaTakao UrabeYasushi OkadaYasuo TerayamaKazunori ToyodaTakehiko NagaoMasayasu MatsumotoYasuo OhashiTetsuji KanekoRetsu FujitaHiroshi OhtsuHisao OgawaHiroyuki DaidaHiroaki ShimokawaYasushi SaitoTakeshi KimuraTeruo InoueMasunori MatsuzakiRyozo Nagai. (2018) High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD). Circulation 137:19, pages 1997-2009.
Crossref
Crossref
Lei Wang, Wenfeng Tan, Fang Wang, Youxuan Shen, Huanping Mei, Yanyan Wang, Yao Ke, Lei Gu, Qiang Wang & Miaojia Zhang. (2017) Artery compliance in patients with rheumatoid arthritis: results from a case-control study. Clinical Rheumatology 37:1, pages 169-177.
Crossref
Crossref
Na-Qiong Wu, Yuan-Lin Guo, Ping Ye, Hong Chen, Yan-Fang Li, Qi Hua, Cheng-Gang Zhu, Ying Gao, Ping Qing, Xiao-Lin Li, Yao Wang, Geng Liu, Qian Dong & Jian-Jun Li. (2017) Statins usage and target achievement of LDL-C level in Chinese patients with coronary artery disease impacted by 2013 ACC/AHA cholesterol guideline. IJC Metabolic & Endocrine 14, pages 33-37.
Crossref
Crossref
N. C. Tan, C. C. Goh, S. C. P. Goh, Y. L. E. Koh & K. H. Koh. (2016) The effect of the intensity of lipid-lowering medications on the LDL cholesterol treatment goals of Asian patients with dyslipidaemia in primary care. Journal of Clinical Pharmacy and Therapeutics 41:6, pages 677-683.
Crossref
Crossref
Ulrich Laufs, Barbara Karmann & David Pittrow. (2016) Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk. Clinical Research in Cardiology 105:9, pages 783-790.
Crossref
Crossref
P Yan, EK Tan, JC Choo, CF Liew, T Lau & DD Waters. (2016) Statin-centric versus low-density lipoprotein-centric approach for atherosclerotic cardiovascular disease prevention: a Singapore perspective. Singapore Medical Journal 57:07, pages 360-367.
Crossref
Crossref